Dr Haryana Dhillon

Research Fellow
Medicine, Central Clinical School

Telephone +61 2 9036 5392
Fax +61 2 9036 5420

Map

Selected grants

2014

  • Informing women about over-diagnosis in mammography screening: a randomised trial; McCaffery K, Barratt A, Jansen J, Houssami N, Dhillon H, McGeechan K; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Development and evaluation of an Australian adult health literacy program for socially disadvantaged adults attending TAFE; McCaffery K, Smith S, Dhillon H, Hayen A, Shepherd H, Comings J, Luxford K, Nutbeam D, Wright C, Wedyan M; Australian Research Council (ARC)/Linkage Projects (LP).
  • PLANET Sydney - the PhysicaL Activity NETwork Sydney University; Bauman A, Kay J, Sherrington C, Rissel C, Greaves S, Mulley C, Gill T, Davis G, Refshauge K, Fiatarone Singh M, Hardy L, Baur L, Allman-Farinelli M, Clemson L, Magnusson R, Kilbreath S, Neubeck A, Dhillon H, Chau J, Johnson N; DVC Research/Research Network Scheme (SyReNS).
  • Development and operational support for the Australasian Lung Cancer Trials Group (ALTG) through the NHMRC Clinical Trial Centre: A NSW-led initiative; Pavlakis N, Boyer M, Stockler M, Dhillon H, Links M, Brown C, Lewis C, Stubbin I; Cancer Institute New South Wales/Cooperative Clinical Trial (CCT) Grants.
  • PoCoG infrastructure to support operational activity and facility management to further psychosocial and supportive care clinical trials; Butow P, Girgis A, Kelly B, Vardy J, Dhillon H, Hobbs K, Price M; Cancer Institute New South Wales/Cooperative Clinical Trial (CCT) Grants.
  • Evaluation of a web-based cognitive rehabilitation programme in cancer survivors with self-reported cognitive impairment; Vardy J, Dhillon H, Bell M, Price M, Cysique L, Bray V; Cancer Council New South Wales/Research Project Grants.

2012

  • The impact of physical activity on fatigue and quality of life in lung cancer patients; Vardy J, Clarke S, Dhillon H, Boyer M; Slater and Gordon Asbestos Research Fund/Vojakovic Fellowship.
  • Analysis of lifestyle risk factor management for the Heart Foundation; Bonner C, McCaffery K, Jansen J, Dhillon H, McKinn S, Irwig L; Heart Foundation of Australia/Research Support.
  • Review and Update of Psychosocial Clinical Practice Guidelines; Butow P, Olver I, Price M, Vardy J, Dhillon H, Thewes B, Best M, Peate M; Cancer Australia/Tender: Systematic reviews to support clinical practice guidelines.
  • Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial; Tattersall M, Vardy J, Dhillon H, Bell M, Cysique L, Boyle F, Clarke S; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Objective Measurement of Physical Activity and Sedentary Behaviours across Twelve NHMRC Funded Studies; Baur L, Van Der Ploeg H, Tiedemann A, Vardy J, Dhillon H, Maher C, Lin C, Chau J, Hardy L, Rissel C, Latimer J, Moseley A, Bauman A; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2010

  • Evaluation of a Web-based Cognitive Rehabilitation Programme in Cancer Survivors with Self Reported Cognitive Impairment; Bray V, Vardy J, Dhillon H, Boyle F; Friends of the Mater/Annual Grant.

2009

  • Caring for thoracic cancer caregivers: Exploring psychological and supportive care needs; Wikaire E, Vardy J, Dhillon H, Price M; Australian Lung Foundation/ALTG Concept Development Grant.
  • Educating patients about chemotherapy and side-effects: What do nurses say?; Dhillon H, Jacquet J, Butow P, Jansen J, Colagiuri B, Cox K; DVC Research/Cancer Research Fund.
  • Phase III Study of the impact of a physical activity program on disease-free survival for early colon cancer; Vardy J, Zalcberg J, Dhillon H, Van Der Ploeg H, Courneya K, Meyer R; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The impact of physical activity on quality of life in lung cancer patients; Vardy J, Dhillon H; Lance Armstrong Foundation/Young Investigator Grant.
  • The impact of physical activity on quality of life in thoracic cancer patients; Vardy J, Dhillon H, Van Der Ploeg H, Clarke S, Boyer M, Bauman A; Lance Armstrong Foundation/Young Investigator Grant.
  • CHALLENGE: Colon Health and Life Long Exercise Change; Courneya K, Vardy J, Meyer R, Dhillon H, Van Der Ploeg H, Zalcberg J; National Health and Medical Research Council (NHMRC)/Project: Large Scale Clinical Trial Grant.
  • Internet-based behaviour change for sleepless cancer patients: How common is sleep disturbance in Australian cancer survivors and are computer-based interventions feasible?; Dhillon H; Psycho-Oncology Cooperative Research Group (PoCoG]/Pilot Grant.

2008

  • Educating patients about chemotherapy - what do nurses say?; Dhillon H; Clinical Oncological Society of Australia/Research Support.
  • Cognitive rehabilitation for breast cancer survivors with perceived cognitive impairment; Vardy J, Dhillon H; Cancer Institute New South Wales/Sponsorship.

2007

  • Cognitive Function and Fatigue in cancer patients after chemotherapy; Vardy J, Clarke S, Tannock I, Schnitzler M, Dhillon H; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • A randomised trial of adjuvant chemotherapies in resectable pancreatic cancer: ESPAC-3; Padbury R, Zalcberg J, Goldstein D, Maddern G, O'Rourke J, Dhillon H; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Oh, B., Dhillon, H. (2012). Barriers to Conducting Complementary and Alternative Medicine Clinical Trials. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 337-356). London: Imperial College Press.
  • Vardy, J., Dhillon, H. (2011). Cognitive Function in Cancer Survivors. In M. P. Davis, P. Feyer, P, Ortner and C. Zimmermann (Eds.), Supportive Oncology, (pp. 448-455). Philadelphia: Elsevier.
  • Vardy, J., Dhillon, H. (2010). Clinical Trials in Survivors of Cancer with Chemotherapy Related Cognitive Impairment. American Society of Clinical Oncology 2010 Educational Book, (pp. 56-59). United States: American Society of Clinical Oncology.

Journals

  • Smith, S., Petrak, L., Dhillon, H., Taylor, J., Milross, C. (2014). Are radiation oncologists aware of health literacy among people with cancer treated with radiotherapy? European Journal of Cancer Care, 23(1), 111-120. [More Information]
  • Dhillon, H. (2014). Cognition after breast cancer. Current Breast Cancer Reports, 6(3), 205-210. [More Information]
  • Bonner, C., Jansen, J., Newell, B., Irwig, L., Glasziou, P., Doust, J., Dhillon, H., McCaffery, K. (2014). I Don't Believe It, But I'd Better Do Something About It: Patient Experiences of Online Heart Age Risk Calculators. Journal of Medical Internet Research, 16(5), 1-17. [More Information]
  • Hersch, J., Barratt, A., Jansen, J., Houssami, N., Irwig, L., Jacklyn, G., Dhillon, H., Thornton, H., McGeechan, K., Howard, K., McCaffery, K. (2014). The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial. BMJ Open, 4(5), 1-10. [More Information]
  • Dong, S., Butow, P., Costa, D., Dhillon, H., Shields, C. (2014). The influence of patient-centered communication during radiotherapy education sessions on post-consultation patient outcomes. Patient Education and Counseling, 95(3), 305-312. [More Information]
  • Connolly, K., Dhillon, H., Mann, B., Chua, B., Segelov, E. (2013). Breast cancer: Screening, prevention, support and other aspects. Medicine Today, 14(8), 29-36.
  • Colagiuri, B., Dhillon, H., Butow, P., Jansen, J., Cox, K., Jacquet, J. (2013). Does Assessing Patients' Expectancies About Chemotherapy Side Effects Influence Their Occurrence? Journal of Pain and Symptom Management, 46(2), 275-281. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Price, M., Dhillon, H. (2013). Review: insufficient evidence to recommend routine screening for psychological distress among people with cancer. Evidence-Based Mental Health, 16(4), 108-108. [More Information]
  • Smith, S., Zhu, Y., Dhillon, H., Milross, C., Taylor, J., Halkett, G., Zilliacus, E. (2013). Supporting patients with low health literacy: what role do radiation therapists play? Supportive Care in Cancer, 21(11), 3051-3061. [More Information]
  • Hersch, J., Jansen, J., Barratt, A., Irwig, L., Houssami, N., Howard, K., Dhillon, H., McCaffery, K. (2013). Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ, 346(7892), 1-13. [More Information]
  • Dhillon, H., Van Der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012). The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol. BMC Cancer, 12, 1-9. [More Information]
  • Oguchi, M., Jansen, J., Butow, P., Colagiuri, B., Divine, R., Dhillon, H. (2011). Measuring the impact of nurse cue-response behaviour on cancer patients' emotional cues. Patient Education and Counseling, 82(2), 163-168. [More Information]
  • Dhillon, H. (2011). Researching complementary and alternative therapies: Frameworks for evaluation. Cancer Forum, 35(1), 23-26.
  • McCaffery, K., Smith, S., Shepherd, H., Sze, M., Dhillon, H., Jansen, J., Juraskova, I., Butow, P., Trevena, L., Carey, K., Tattersall, M., Barratt, A. (2011). Shared decision making in Australia in 2011. German Journal for Evidence and Quality in Health Care (Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen), 105(4), 234-239. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]
  • Vardy, J., Dhillon, H. (2010). The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast Cancer Research and Treatment, 123(1), 35-37. [More Information]
  • Chua, W., Goldstein, D., Lee, C., Dhillon, H., Michael, M., Mitchell, P., Clark, S., Iacopetta, B. (2009). Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. British Journal of Cancer, 101(6), 998-1004. [More Information]
  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67.
  • Courneya, K., Booth, C., Gill, S., O'Brien, P., Vardy, J., Friedenreich, C., Au, H., Brundage, M., Tu, D., Dhillon, H., et al (2008). The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Current Oncology, 15(6), 8-16. [More Information]
  • Findlay, M., Storey, D., Gebski, V., Hargreaves, C., Cullingford, G., Boyer, M., Trotter, J., Archer, S., Davidson, A., Johnston, P., Yuen, J., Dhillon, H., et al (2007). A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group study 9601. ANZ Journal of Surgery, 77(4), 247-252.
  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]
  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]
  • Ackland, S., Jones, M., Tu, D., Simes, R., Yuen, J., Sargeant, A., Dhillon, H., Goldberg, R., Abdi, E., Moore, M., et al (2005). A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. British Journal of Cancer, 93(11), 1236-1243. [More Information]
  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Beith, J., Sullivan, A., Boyle, F., Dhillon, H., Coates, A., Simes, R. (2004). Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC). Journal of Clinical Oncology, 22(14S), 73S-73S.
  • Coates, A., Thompson, J., McMullen, A., Simes, R., McCarthy, W., Hersey, P., Sillar, R., Mcleod, R., Gill, P., Coventry, B., Dhillon, H. (2002). Adjuvant Immunotherapy of Patients with High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial. Journal of Clinical Oncology, 20(20), 4181-4189.
  • Cuzick, J., Forbes, J., Edwards, R., Baum, M., Cawthorn, S., Coates, A., Hamed, H., Howell, A., Powels, T., Dhillon, H., Gebski, V., Simes, R. (2002). First results from the International Breast Cancer Intervention Study (IBIS-1): a randomised prevention trial. The Lancet, 360(9336), 817-824.
  • Cuzjik, J., Dhillon, H., Gebski, V., Simes, R. (2002). First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. The Lancet, 360(9336), 817-824.
  • Toner, G., Stockler, M., Boyer, M., Jones, M., Thomson, D., Harvey, V., Olver, I., Dhillon, H., McMullen, A., Gebski, V., Levi, J., Simes, R. (2001). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. The Lancet, 357(9528), 739-745.

Conferences

  • Cullingford, G., Findlay, M., Storey, D., Boyer, M., Trotter, J., Archer, S., Davidson, A., Johnston, P., Gebski, V., Dhillon, H. (2002). A phase II feasibility study of pre-operative and post-operative chemotherapy (epirubicin, cisplatin and 4FU (ECF)) in patients with advanced but operable gastric cancer: and Australasian Gastro-Intestinal Trials Group (AGITG) study (AG9601). 38th Annual Meeting of ASCO.

2014

  • Smith, S., Petrak, L., Dhillon, H., Taylor, J., Milross, C. (2014). Are radiation oncologists aware of health literacy among people with cancer treated with radiotherapy? European Journal of Cancer Care, 23(1), 111-120. [More Information]
  • Dhillon, H. (2014). Cognition after breast cancer. Current Breast Cancer Reports, 6(3), 205-210. [More Information]
  • Bonner, C., Jansen, J., Newell, B., Irwig, L., Glasziou, P., Doust, J., Dhillon, H., McCaffery, K. (2014). I Don't Believe It, But I'd Better Do Something About It: Patient Experiences of Online Heart Age Risk Calculators. Journal of Medical Internet Research, 16(5), 1-17. [More Information]
  • Hersch, J., Barratt, A., Jansen, J., Houssami, N., Irwig, L., Jacklyn, G., Dhillon, H., Thornton, H., McGeechan, K., Howard, K., McCaffery, K. (2014). The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial. BMJ Open, 4(5), 1-10. [More Information]
  • Dong, S., Butow, P., Costa, D., Dhillon, H., Shields, C. (2014). The influence of patient-centered communication during radiotherapy education sessions on post-consultation patient outcomes. Patient Education and Counseling, 95(3), 305-312. [More Information]

2013

  • Connolly, K., Dhillon, H., Mann, B., Chua, B., Segelov, E. (2013). Breast cancer: Screening, prevention, support and other aspects. Medicine Today, 14(8), 29-36.
  • Colagiuri, B., Dhillon, H., Butow, P., Jansen, J., Cox, K., Jacquet, J. (2013). Does Assessing Patients' Expectancies About Chemotherapy Side Effects Influence Their Occurrence? Journal of Pain and Symptom Management, 46(2), 275-281. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Price, M., Dhillon, H. (2013). Review: insufficient evidence to recommend routine screening for psychological distress among people with cancer. Evidence-Based Mental Health, 16(4), 108-108. [More Information]
  • Smith, S., Zhu, Y., Dhillon, H., Milross, C., Taylor, J., Halkett, G., Zilliacus, E. (2013). Supporting patients with low health literacy: what role do radiation therapists play? Supportive Care in Cancer, 21(11), 3051-3061. [More Information]
  • Hersch, J., Jansen, J., Barratt, A., Irwig, L., Houssami, N., Howard, K., Dhillon, H., McCaffery, K. (2013). Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ, 346(7892), 1-13. [More Information]

2012

  • Oh, B., Dhillon, H. (2012). Barriers to Conducting Complementary and Alternative Medicine Clinical Trials. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 337-356). London: Imperial College Press.
  • Dhillon, H., Van Der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012). The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol. BMC Cancer, 12, 1-9. [More Information]

2011

  • Vardy, J., Dhillon, H. (2011). Cognitive Function in Cancer Survivors. In M. P. Davis, P. Feyer, P, Ortner and C. Zimmermann (Eds.), Supportive Oncology, (pp. 448-455). Philadelphia: Elsevier.
  • Oguchi, M., Jansen, J., Butow, P., Colagiuri, B., Divine, R., Dhillon, H. (2011). Measuring the impact of nurse cue-response behaviour on cancer patients' emotional cues. Patient Education and Counseling, 82(2), 163-168. [More Information]
  • Dhillon, H. (2011). Researching complementary and alternative therapies: Frameworks for evaluation. Cancer Forum, 35(1), 23-26.
  • McCaffery, K., Smith, S., Shepherd, H., Sze, M., Dhillon, H., Jansen, J., Juraskova, I., Butow, P., Trevena, L., Carey, K., Tattersall, M., Barratt, A. (2011). Shared decision making in Australia in 2011. German Journal for Evidence and Quality in Health Care (Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen), 105(4), 234-239. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]

2010

  • Vardy, J., Dhillon, H. (2010). Clinical Trials in Survivors of Cancer with Chemotherapy Related Cognitive Impairment. American Society of Clinical Oncology 2010 Educational Book, (pp. 56-59). United States: American Society of Clinical Oncology.
  • Vardy, J., Dhillon, H. (2010). The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast Cancer Research and Treatment, 123(1), 35-37. [More Information]

2009

  • Chua, W., Goldstein, D., Lee, C., Dhillon, H., Michael, M., Mitchell, P., Clark, S., Iacopetta, B. (2009). Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. British Journal of Cancer, 101(6), 998-1004. [More Information]

2008

  • Nowak, A., Cebon, J., Hargreaves, C., Dhillon, H., Findlay, M., Gebski, V., Stockler, M. (2008). Assessment of health-related quality of life and patient benefit as outcome measures for clinical trials in hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology, 4, 55-67.
  • Courneya, K., Booth, C., Gill, S., O'Brien, P., Vardy, J., Friedenreich, C., Au, H., Brundage, M., Tu, D., Dhillon, H., et al (2008). The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Current Oncology, 15(6), 8-16. [More Information]

2007

  • Findlay, M., Storey, D., Gebski, V., Hargreaves, C., Cullingford, G., Boyer, M., Trotter, J., Archer, S., Davidson, A., Johnston, P., Yuen, J., Dhillon, H., et al (2007). A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group study 9601. ANZ Journal of Surgery, 77(4), 247-252.
  • Stockler, M., O'Connell, R., Nowak, A., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E., Glasgow, A., Beale, P., Dhillon, H., Heritier, S., Carter, C., Hickie, I., Simes, R., et al (2007). Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncology, 8(7), 603-612. [More Information]

2006

  • Cebon, J., Hargreaves, C., Stockler, M., Boyer, M., Nowak, A., Dhillon, H., Gebski, V., Dickman, B., Findlay, M., Poon, A., et al (2006). Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. British Journal of Cancer, 95(7), 853-861. [More Information]

2005

  • Ackland, S., Jones, M., Tu, D., Simes, R., Yuen, J., Sargeant, A., Dhillon, H., Goldberg, R., Abdi, E., Moore, M., et al (2005). A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. British Journal of Cancer, 93(11), 1236-1243. [More Information]

2004

  • Duric, V., Stockler, M., Butow, P., Sharpe, L., Beith, J., Sullivan, A., Boyle, F., Dhillon, H., Coates, A., Simes, R. (2004). Predictors of the benefits women consider necessary to make adjuvant chemotherapy (ACT) worthwhile for early breast cancer (EBC). Journal of Clinical Oncology, 22(14S), 73S-73S.

2002

  • Cullingford, G., Findlay, M., Storey, D., Boyer, M., Trotter, J., Archer, S., Davidson, A., Johnston, P., Gebski, V., Dhillon, H. (2002). A phase II feasibility study of pre-operative and post-operative chemotherapy (epirubicin, cisplatin and 4FU (ECF)) in patients with advanced but operable gastric cancer: and Australasian Gastro-Intestinal Trials Group (AGITG) study (AG9601). 38th Annual Meeting of ASCO.
  • Coates, A., Thompson, J., McMullen, A., Simes, R., McCarthy, W., Hersey, P., Sillar, R., Mcleod, R., Gill, P., Coventry, B., Dhillon, H. (2002). Adjuvant Immunotherapy of Patients with High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial. Journal of Clinical Oncology, 20(20), 4181-4189.
  • Cuzick, J., Forbes, J., Edwards, R., Baum, M., Cawthorn, S., Coates, A., Hamed, H., Howell, A., Powels, T., Dhillon, H., Gebski, V., Simes, R. (2002). First results from the International Breast Cancer Intervention Study (IBIS-1): a randomised prevention trial. The Lancet, 360(9336), 817-824.
  • Cuzjik, J., Dhillon, H., Gebski, V., Simes, R. (2002). First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. The Lancet, 360(9336), 817-824.

2001

  • Toner, G., Stockler, M., Boyer, M., Jones, M., Thomson, D., Harvey, V., Olver, I., Dhillon, H., McMullen, A., Gebski, V., Levi, J., Simes, R. (2001). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. The Lancet, 357(9528), 739-745.

To update your profile click here. For support on your academic profile contact .